LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Symmetry Medical Launches Offset Acetabular Reamer Driver
Large Joints and Extremities

Symmetry Medical Launches Offset Acetabular Reamer Driver

June 13, 2014 2 min read Premium comments

Advertisement

Symmetry Medical Launches Offset Acetabular Reamer Driver
Dual Connection Offset Acetabular Reamer Driver/Symmetry Medical Inc.
Secondary

Symmetry Medical Inc. has announced that it has launched the Dual Connection Offset Acetabular Reamer Driver through its OEM Solutions team. Symmetry indicates that its new Dual Connection Offset Acetabular Reamer Driver is used during total hip arthroplasty (THA) surgery to easily introduce acetabular reamers to the hip joint and to enhance visibility in minimally invasive procedures such as Direct Anterior Approach THA surgery. The driver features a patented drive shaft assembly designed and tested to meet the demands of THA surgery.

The product highlights include:

  • Improved access to the acetabulum due to the low-profile reamer/driver connection
  • Innovative design allowing easy disassembly to facilitate the cleaning and sterilization of the internal components
  • An ergonomic silicone over-molded stabilization handle
  • Compatibility with Symmetry’s flagship 420SS Acetabular Reamers as well as the Low-Profile Parabolic Reamers

Thomas W. Barrett, senior vice president and chief commercial officer, Symmetry Medical OEM Solutions, said in the June 11, 2014 news release, “The launch of the Dual Connection Offset Acetabular Reamer Driver is a significant advancement in our proven line of acetabular preparation products and further enhances our comprehensive offering of instruments for the anterior surgical approach for hip arthroplasty. Our New Product Development team tested this device extensively to validate the mechanical longevity with a focus in optimizing the long term functional performance and the overall ease of use. By providing valuable proprietary product innovation that can be added to our customers’ surgical instrument sets, we continue to support our OEM customers, orthopedic surgeons and the patients that they serve.”

Barrett told OTW, “With the addition of the new dual connection offset acetabular reamer driver, we feel Symmetry Medical has the broadest product portfolio to service our customer’s needs for direct anterior approach hip arthroplasty. This procedure is growing in popularity due to the benefits it provides for patients and there has been an opportunity for improvement specifically in the area of instrumentation for preparing the acetabulum. The new Symmetry product was tested thoroughly by Symmetry Medical R&D and has documented performance longevity and a design with minimum components which results in optimum ease of use for cleaning and sterilization—both of which have been fully validated and are available to our customers. Our goal is to make it a simple process for our OEM customers to integrate this product into their existing hip instrument systems.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy